Web This site Trusted
9 result(s) for “okapi bm25 site terms com pp site github com site get to eu site huggingface co site:www.owkin.com” · 891 ms
Scope: Nishi’s own index (our crawl + Common Crawl) — not the whole live web. Some sites block all automated crawlers (anti-bot walls), so their pages may be absent here even though we never filter lawful content.
Freshness: no result on this page carries a fetch time yet (indexed before the fetch epoch was stored beside the doc)
https://www.owkin.com/diagnostics/next-gen-ai-dx
We need to process your personal data in order to deal with your request
https://www.owkin.com/publications/how-to-estimate-the-age-of-your-brain-with-mri-data
Similarly, data scientists will need to collaborate closely with doctors to focus on relevant medical questions and understand patients behind the data
https://www.owkin.com/conference-posters/ai-biotech-in-action
We need to process your personal data in order to deal with your request
https://www.owkin.com/newsfeed/nhs-trust-and-owkin-to-develop-ai-tool-to-combat-her2-breast-cancer
to develop an AI model to speed up the diagnosis of one of the most aggressive forms of breast cancer
https://www.owkin.com/publications/diagnosis-of-focal-liver-lesions-from-ultrasound-using-deep-learning
This method could prove to be highly relevant for medical imaging once validated on a larger independent cohort
https://www.owkin.com/faqs/are-external-experts-or-the-academic-community-involved-in-shaping-the-development-of-k-pro
We have also invited the academic community to be amongst beta testers and early users, to have scientists help us build K Pro for scientists
https://www.owkin.com/newsfeed/owkin-unveils-ai-driven-oncology-and-immunology-pipeline-in-licenses-best-in-class-asset-okn4395
With this best-in-class asset, Owkin can now unleash its capacity to decipher complex biology to get us one step closer to finding the right treatment for every patient
https://www.owkin.com/blogs-case-studies/from-banking-to-big-pharma-to-ai-biotech-alban-de-la-sablieres-take-on-jpm-and-industry-trends
First, having had meetings with most big pharmas, it was clear that all had a very significant investment in AI drug discovery and development and were very clear about how they wanted their R&D platforms to look in five years' time, at least in terms of improved productivity with an objective to cut drug development
https://www.owkin.com/a-z-of-ai-for-healthcare/prediction
, co-morbidities) interact to alter risk level
each individual outcome of interest requires a new bespoke-trained model
the range of variables (for example phenotypic, or genetic, or ‘clinical’) that they can handle is limited